NervGen Pharma (NGEN) Balance Sheet: Assets & Liabilities

NervGen Pharma (NGEN) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2025), NervGen Pharma reported total assets of CAD 23.21M and total liabilities of CAD 19.73M. Shareholders' equity was CAD 3.48M, up 35.0% from CAD 2.57M a year earlier. Total debt stood at CAD 8.37K against CAD 22.07M in cash and short-term investments, a net cash position of CAD 22.06M. That puts debt-to-equity at 0.00, compared with 0.04 a year earlier.

NervGen Pharma Balance Sheet Analysis

Values in millions CAD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for NervGen Pharma Corp. (NGEN) - Annual data in millions CAD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Mar 2021	Dec 2020	Mar 2020	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	22.07	22.07	17.26	17.27	11.66	11.66	22.25	17.06	5.61	5.60	4.22	2.47	0.00
Short-Term Investments	0.00	0.01	0.10	0.10	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Cash & Short-Term Investments	22.07	22.08	17.35	17.36	11.66	11.66	22.25	17.06	5.61	5.60	4.22	2.47	0.00
Accounts Receivable	0.08	0.08	0.42	0.42	0.25	0.25	0.03	0.06	0.06	0.06	0.13	0.03	0.00
Inventory	0.00	-	0.00	-	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Other Current Assets	0.65	0.64	1.23	0.11	0.61	0.02	0.66	0.43	0.54	0.05	2.08	0.05	0.00
Total Current Assets	22.80	22.80	19.00	19.01	12.52	12.52	22.94	17.55	6.22	6.20	6.43	2.54	0.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	-	0.00	-	0.20	0.20	0.29	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	0.00	-	0.01	-	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Intangible Assets	0.41	0.41	0.46	0.46	0.52	0.52	0.43	0.48	0.47	0.47	0.52	0.55	0.00
Other Non-Current Assets	0.00	-	0.00	-	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.08
Total Non-Current Assets	0.41	0.41	0.47	0.47	0.72	0.72	0.72	0.48	0.47	-	0.52	0.55	0.08
Total Assets	23.21	23.21	19.47	19.49	13.24	13.24	23.67	18.03	6.69	6.68	6.95	3.09	0.08
Current Liabilities
Accounts Payable	4.66	0.03	0.00	0.03	0.00	3.32	0.00	0.00	0.00	0.17	0.00	0.00	0.06
Short-Term Debt	0.01	-	0.10	-	0.09	-	0.09	0.00	0.00	-	0.00	0.00	0.00
Accrued Liabilities	-	3.27	-	3.75	-	2.55	0.89	0.73	-	0.58	-	-	-
Other Current Liabilities	15.07	15.07	16.79	11.86	15.05	11.79	10.04	1.09	0.76	-	0.95	0.45	0.04
Total Current Liabilities	19.73	19.73	16.89	16.90	15.14	15.14	10.13	1.09	0.76	0.76	0.95	0.45	0.10
Non-Current Liabilities
Long-Term Debt	0.00	-	0.01	0.01	0.11	0.11	0.20	0.00	0.00	-	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	-	0.00	-	0.00	-	0.00	0.00	0.00	-	0.00	0.13	0.00
Total Non-Current Liabilities	0.00	-	0.01	0.01	0.11	0.11	0.20	0.00	0.00	-	0.00	0.13	0.00
Total Liabilities	19.73	19.73	16.90	16.91	15.25	15.25	10.32	1.09	0.76	0.76	0.95	0.58	0.10
Stockholders' Equity
Common Stock	103.00	103.00	81.05	81.19	58.94	58.93	56.91	42.73	23.00	22.95	15.71	3.83	0.00
Retained Earnings	-146.76	-146.76	-102.09	-102.65	-78.16	-78.15	-55.28	-35.32	-22.37	-22.32	-11.44	-1.37	-0.01
Accumulated Other Comprehensive Income	0.00	47.24	23.64	24.03	17.21	17.21	11.82	9.46	5.30	5.30	1.68	0.04	0.00
Additional Paid-in Capital	47.24	-	0.00	-	-	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Shares Outstanding	-	79.65	-	70.33	-	59.61	58.78	46.19	-	-	-	-	-
Total Stockholders' Equity	3.48	3.48	2.57	2.58	-2.01	-2.01	13.34	16.95	5.93	5.92	6.00	2.51	-0.01
Total Liabilities & Equity	23.21	23.21	19.49	19.49	13.24	13.24	23.88	17.90	6.68	-	6.77	3.10	0.08

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NervGen Pharma Balance Sheet

How much debt does NervGen Pharma have?

NervGen Pharma had total debt of CAD 8.37K as of Mar 31, 2026, against CAD 22.07M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was CAD 105.53K a year earlier.

What are NervGen Pharma's total assets?

NervGen Pharma reported total assets of CAD 23.21M as of Mar 31, 2026, up 19.2% from CAD 19.47M a year earlier. Total liabilities were CAD 19.73M.

What is NervGen Pharma's shareholders' equity?

NervGen Pharma's shareholders' equity was CAD 3.48M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition